Pfizer Names New Executives to Run Units After Allergan Deal

  • Geno Germano, president of innovative drugs unit, to step down
  • Allergan executive will lead new division housing Botox

Pfizer Inc. announced a new leadership structure for when it closes its about $160 billion deal with Allergan Plc, naming two Pfizer executives and an Allergan employee to run three different segments within the company’s two main businesses.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.